REPURPOSING SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS FOR GEROTHERAPY

被引：0
|
作者：
Espinoza, Sara [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA USA
来源：
INNOVATION IN AGING | 2024年 / 8卷
关键词：
D O I：
10.1093/geroni/igae098.0451
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
igae098.04
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [1] Sodium-glucose co-transporter-2 inhibitors and epicardial adiposity
    Yaribeygi, Habib
    Maleki, Mina
    Butler, Alexandra E.
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 180
  • [2] A review of the safety of sodium-glucose co-transporter-2 inhibitors
    O'Hara, Daniel Vincent
    Jardine, Meg J.
    DIABETES OBESITY & METABOLISM, 2025,
  • [3] The Evolution of Sodium-Glucose Co-Transporter-2 Inhibitors in Heart Failure
    Fadiran, Olusayo
    Nwabuo, Chike
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [4] Sodium-glucose co-transporter-2 inhibitors : a potential cardioprotective agent?
    Stratinaki, M.
    Maragkoudakis, S.
    Stavrakis, S.
    Papoutsaki, E.
    Korela, D.
    Aletras, G.
    Honda, E.
    Garidas, G.
    Georgopoulou, T.
    Eleftheriadou, E.
    Pitarokoilis, M.
    Liapi, D.
    Kafkala, K.
    Foukarakis, E.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [5] Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors
    Perelman, Moran Gvili
    Brzezinski, Rafael Y.
    Waissengrin, Barliz
    Leshem, Yasmin
    Bainhoren, Or
    Rubinstein, Tammi Arbel
    Perelman, Maxim
    Rozenbaum, Zach
    Havakuk, Ofer
    Topilsky, Yan
    Banai, Shmuel
    Wolf, Ido
    Laufer-Perl, Michal
    CARDIO-ONCOLOGY, 2024, 10 (01)
  • [6] Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors
    Moran Gvili Perelman
    Rafael Y. Brzezinski
    Barliz Waissengrin
    Yasmin Leshem
    Or Bainhoren
    Tammi Arbel Rubinstein
    Maxim Perelman
    Zach Rozenbaum
    Ofer Havakuk
    Yan Topilsky
    Shmuel Banai
    Ido Wolf
    Michal Laufer-Perl
    Cardio-Oncology, 10
  • [7] Effectiveness of sodium-glucose co-transporter-2 inhibitors on ischaemic heart disease
    Shen, Yun
    Zhou, Jian
    Shi, Lizheng
    Nauman, Elizabeth
    Katzmarzyk, Peter T.
    Price-Haywood, Eboni G.
    Horswell, Ronald
    Chu, San
    Yang, Shengping
    Bazzano, Alessandra N.
    Nigam, Somesh
    Hu, Gang
    DIABETES OBESITY & METABOLISM, 2020, 22 (07): : 1197 - 1206
  • [8] Myeloproliferative Neoplasms and Sodium-Glucose Co-Transporter-2 Inhibitors: A Case Series
    Patir, Pusem
    Cerci, Kubra
    Kurtoglu, Erdal
    TURKISH JOURNAL OF HEMATOLOGY, 2024, 41 (02) : 130 - 132
  • [9] An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus
    Hsia, Daniel S.
    Grove, Owen
    Cefalu, William T.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2017, 24 (01) : 73 - 79
  • [10] The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis
    Stachteas, Panagiotis
    Karakasis, Paschalis
    Patoulias, Dimitrios
    Clemenza, Francesco
    Fragakis, Nikolaos
    Rizzo, Manfredi
    ANNALS OF MEDICINE, 2023, 55 (02)
12345